Publicacións en colaboración con investigadores/as de Hospital Universitario Reina Sofia (6)

2023

  1. Efficacy and Safety of Intraoperative Hyperthermic Intraperitoneal Chemotherapy for Locally Advanced Colon Cancer: A Phase 3 Randomized Clinical Trial

    JAMA surgery

2022

  1. GECOP-MMC: phase IV randomized clinical trial to evaluate the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) with mytomicin-C after complete surgical cytoreduction in patients with colon cancer peritoneal metastases

    BMC Cancer, Vol. 22, Núm. 1

2019

  1. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Gastric Cancer with Peritoneal Carcinomatosis: Multicenter Study of Spanish Group of Peritoneal Oncologic Surgery (GECOP)

    Annals of Surgical Oncology, Vol. 26, Núm. 8, pp. 2615-2621

  2. RAS Mutation Decreases Overall Survival After Optimal Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy of Colorectal Peritoneal Metastasis: A Modification Proposal of the Peritoneal Surface Disease Severity Score

    Annals of Surgical Oncology, Vol. 26, Núm. 8, pp. 2595-2604

2018

  1. Current practice in cytoreductive surgery and HIPEC for metastatic peritoneal disease: Spanish multicentric survey

    European Journal of Surgical Oncology, Vol. 44, Núm. 2, pp. 228-236

  2. HIPECT4: Multicentre, randomized clinical trial to evaluate safety and efficacy of Hyperthermic intra-peritoneal chemotherapy (HIPEC) with Mitomycin C used during surgery for treatment of locally advanced colorectal carcinoma

    BMC Cancer, Vol. 18, Núm. 1